Home > Analytics > VENUS REMEDIES

VENUS REMEDIES
Intrinsic Value | Fundamental Analysis

BOM : 526953     NSE : VENUSREM    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Average [Stock is fairly valued]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Nov 26,2024
Price(EOD): ₹ 297.15
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 398.18 Cr
Value of ₹ 1 Lac invested in VENUS REMEDIES
on Nov 26,2019 (price: ₹ 22.50)

₹ 1 L

₹ 13.21 L

1W : 0.9% 1M : -7.7% 1Y : -19.9%
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results
Industry Peers & Returns1W1M1Y
VENUS REMEDIES 0.9% -7.7% -19.9%
SUN PHARMACEUTICAL INDUSTRIES -0.9% -4.8% 50.2%
CIPLA 1.5% 0.1% 19.9%
DR REDDYS LABORATORIES -0.4% -8.2% 7.1%
ZYDUS LIFESCIENCES 0.6% -5.3% 51%
DIVIS LABORATORIES 3% 5.9% 65%
MANKIND PHARMA 0.6% 3.1% 34.4%
TORRENT PHARMACEUTICALS 4.3% -2.7% 54.2%
LUPIN -0.1% -4.4% 72.4%

FUNDAMENTAL ANALYSIS OF VENUS REMEDIES

 
Fundamentals Score
[ Q(TTM): Sep2024, Y: Mar2024
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF VENUS REMEDIES

 
Valuation Score
[As on : Nov 26,2024 ]

Ratio Consolidated
P/E
P/B
P/S
17.98
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 22.09 Cr
[Latest Qtr - Sep2024 - Consolidated Results ]

0.81
P/B Calculated based on Book Value of Rs 487.55 Cr
[Latest Year - Mar2024 - Consolidated Results ]

0.65
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 614.64 Cr
[Latest Qtr - Sep2024 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 9% undervalued companies ! Discover More →

FAIR VALUE OF VENUS REMEDIES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-0%
-41%
87%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF VENUS REMEDIES



VENUS REMEDIES vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF VENUS REMEDIES

Year Debt/Equity ratio
Standalone Consolidated
2024
2023
2022
Avg_3yrs
0.08
0.08
0.09
0.08
0.08
0.09
0.1
0.09
[Last Annual Data : Mar2024]
Financial Ratios →

PLEDGED PROMOTER SHARES OF VENUS REMEDIES

Pledged Promoter Shares
0 %
As on : Dec2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF VENUS REMEDIES

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
54.18%
-56.39%
32.41%
187.71%
-0.16%
-72.34%
-36.75%
-64.69%
QtrlyTrend
-2
Latest Qtr: Sep2024
Quarterly Result Analysis →


VENUS REMEDIES related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about VENUS REMEDIES


Is VENUS REMEDIES good for long term investment?

As on Nov 26,2024, the Fundamentals of VENUS REMEDIES look Poor and hence it may not be good for long term investment ! See Financial Performance of VENUS REMEDIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is VENUS REMEDIES UnderValued or OverValued?

As on Nov 26,2024, VENUS REMEDIES is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of VENUS REMEDIES ?

As on Nov 26,2024, the Intrinsic Value of VENUS REMEDIES is Rs. 297.39 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 297.39
Fair Value [Median EV / Sales Model] : Rs. 505.63
Fair Value [Median Price / Sales Model] : Rs. 158.86
Estimated Median Fair Value of VENUS REMEDIES : Rs. 297.39

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is VENUS REMEDIES trading at a Premium or Discount?

As on Nov 26,2024, VENUS REMEDIES is trading at a Discount of -0% based on the estimates of Median Intrinsic Value!